Skip to main content

PRESS RELEASES

PRESS RELEASES
BNTX

Positive Phase 1 Data From MRNA-based Individualized Neoantigen Specific Immunotherapy In Patients With Resected Pancreatic Cancer Presented At ASCO

By GlobeNewswire
14 minutes ago
PRESS RELEASES

Merus Presents Clinical Data On Zenocutuzumab (Zeno) In NRG1-fusion (NRG1 ) Cancer At The 2022 American Society Of Clinical Oncology (ASCO) Annual Meeting (Oral Abstract)

By GlobeNewswire
1 hour ago
PRESS RELEASES
NANONBTX

NANOBIOTIX: New Data Featuring NBTXR3 Plus Chemoradiation And In The Preoperative Setting Support Broad Applicability For Head And Neck Cancer And Other Solid Tumor Indications

By Business Wire
3 hours ago
PRESS RELEASES
CYT

CYT-0851 Phase 1 Dose Escalation Results Show Early Clinical Activity And Generally Well Tolerated Safety Profile In Advanced Solid Tumors And Hematologic Malignancies

By Business Wire
4 hours ago
PRESS RELEASES

Clover Provides Update On 2022 Corporate Milestones

By GlobeNewswire
5 hours ago
PRESS RELEASES
CNTA

Centessa Pharmaceuticals Announces Poster Presentation Of First Preclinical Data For LockBody® Program At 2022 ASCO Annual Meeting

By GlobeNewswire
5 hours ago
PRESS RELEASES
VTVT

VTv Therapeutics Announces Publication In Diabetes Obesity And Metabolism Of Complete Results For The Mechanistic Study Assessing Effects Of TTP399 On Ketones During Acute Insulin Withdrawal In Patients With Type 1 Diabetes

By GlobeNewswire
Jun 4, 2022 11:00 AM EDT
PRESS RELEASES
BMEA

Biomea Fusion Presents Novel Preclinical Data At ADA 2022 Suggesting BMF-219's Potential As An Oral, Long-Acting Treatment For Type 2 Diabetes

By GlobeNewswire
Jun 4, 2022 11:00 AM EDT
PRESS RELEASES
PBYI

Puma Biotechnology At ASCO 2022 - SUMMIT Trial, Biliary Tract Cancer Poster

By Business Wire
Jun 4, 2022 9:05 AM EDT
PRESS RELEASES
GILD

Sub-analyses Of Landmark ZUMA-7 Trial Reinforce Yescarta® CAR T-cell Therapy Superiority Over Standard Of Care (SOC) As Initial Treatment For Patients With Relapsed Or Refractory Large B-cell Lymphoma (LBCL)

By Business Wire
Jun 4, 2022 9:00 AM EDT